Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

AIMS: Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke prevention in atrial fibrillation (AF). We analysed the time in this therapeutic range (TTR) of VKA-treated patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Sylvia, ten Cate, Hugo, Accetta, Gabriele, Angchaisuksiri, Pantep, Bassand, Jean-Pierre, Camm, A. John, Corbalan, Ramon, Darius, Harald, Fitzmaurice, David A., Goldhaber, Samuel Z., Goto, Shinya, Jacobson, Barry, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, Pieper, Karen, Schellong, Sebastian M., Stepinska, Janina, Turpie, Alexander G. G., van Eickels, Martin, Kakkar, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085020/
https://www.ncbi.nlm.nih.gov/pubmed/27792741
http://dx.doi.org/10.1371/journal.pone.0164076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085020/
https://www.ncbi.nlm.nih.gov/pubmed/27792741
http://dx.doi.org/10.1371/journal.pone.0164076

Ejemplares similares